Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors

Cierna, Z., Mego, M., Miskovska, V., Machalekova, K., Chovanec, M., Svetlovska, D., Hainova, K., Rejlekova, K., Macak, D., Spanik, S., Ondrus, D., Kajo, K., Mardiak, J., Babal, P.·2016·Annals of Oncology
DOI 10.1093/annonc/mdv574

Cited by (164)

Items 101–164 of 164

  1. Identification of programmed cell death 1 and its ligand in the testicular tissue of mice
    Li‐Ling Wang, Zhihui Li, Yong‐Gang Duan, Shuiqiao Yuan, Gil Mor, Aihua Liao · 2018 · American Journal of Reproductive Immunology
  2. Management trends and outcomes of pineal germinoma in a multi-institutional Australian cohort
    Sean Stephens, Anna Kuchel, Robyn Cheuk, Hamish Alexander, Thomas Robertson, Thulasi Rajah, Quan Tran, Po-Ling Inglis · 2021 · Journal of Clinical Neuroscience
  3. Immunotherapy for genitourinary cancer
    Carlo Cattrini, Chiara Dellepiane, Alessia Cavo, Giulia Buzzatti, Francesco Tolomeo, Carlo G. M. Messina, Francesco Boccardo · 2016 · Anti-Cancer Drugs
  4. Research Progress of PD 1/PD L1 Inhibitors in the Treatment of Urological Tumors
    Lv Han, Meng Yang, Zhu Jianguo · 2024 · Current Cancer Drug Targets
  5. Exploiting potential molecular compounds for treating testicular seminoma by targeting immune related genes
    Yankang Cui, Xiaodie Zhou, Jing Zhang, Bo Fang, Jingping Ge, Hao Tang, Bianjiang Liu, Haowei He, Feng Xu, Xue‐Jun Shang · 2024 · Cell Communication and Signaling
  6. Potential therapeutic targets and biomarkers in testicular germ cell tumor oncogenesis
    Francesco Esposito, Marco De Martino, Viviana Franco, Alfredo Fusco, Paolo Chieffi · 2025 · Expert Opinion on Therapeutic Targets
  7. Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review
    Francesco Pierantoni, Caliciotti Fabiana, Selma Ahcene Djaballah, Eleonora Lai, Davide Bimbatti, Silvia Stragliotto, Ilaria Zampiva, Melissa Ballestrin, P. Maria Chiara, Salim Jubran et al. · 2026 · Tumori Journal
  8. Contemporary Role of Radiation Therapy in Testicular Cancer
    Jay C. Shiao, Xinglei Shen · 2024 · Urologic Clinics of North America
  9. Novel treatment options for refractory Germ Cell Tumours: back to the bench!
    Christian Kollmannsberger, Lucia Nappi, Craig R. Nichols · 2017 · Annals of Oncology
  10. Frequent expression of CD45RO memory T cell marker as well as low to high expression of PD-1 and PD-L1 inhibitory molecules in seminoma and dysgerminoma
    Hadiseh Farahani, Amirreza Dehghanian, Aida Khademolhosseini, Mohammad Reza Haghshenas, Nasrollah Erfani · 2023 · Journal of Reproductive Immunology
  11. Pediatric primary extragonadal choriocarcinoma - A study on male patients at a single tertiary medical institution
    Jui‐Ju Tseng, Chi-Yen Chen, Chiung‐Wen Liang, Fang‐Liang Huang · 2024 · Pediatrics & Neonatology
  12. Gastric yolk sac tumor with synchronous liver metastasis: first case report in China
    Yanqing Li, Gang Wang, Xiaofei Cheng · 2019 · Translational Cancer Research
  13. Sustained Response to Anti-PD-1 Therapy in Combination with Nab-Paclitaxel in Metastatic Testicular Germ Cell Tumor Harboring the KRAS-G12V Mutation: A Case Report
    Jin-feng Pan, Weiqi Yin, Yingzhi Chen, Hui Wang, Wei Wu, Suying Wang, Da Li, Qi Ma · 2024 · Urologia Internationalis
  14. Recent developments in the management of germ cell tumors
    Pavlos Msaouel, Mehmet Asım Bilen, Miao Zhang, Matthew T. Campbell, Jennifer Rui Wang, Shi‐Ming Tu · 2017 · Current Opinion in Oncology
  15. Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
    Shi‐Ming Tu, Ahmet Murat Aydın, Sanjay Maraboyina, Zhong‐Ning Chen, Sunny R. K. Singh, Neriman Gökden, Timothy Langford · 2023 · Cancers
  16. A Case of Primary Mediastinal Choriocarcinoma in an Elderly Woman
    Shouichi Okamoto, Jun Ito, Hitomi Yoshikawa, Shunsuke Kato, Kazuhisa Takahashi · 2017 · Haigan
  17. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours
    Adriana M. Pedraza, Andrew J. Stephenson · 2018 · Current Opinion in Urology
  18. Pineal Gland Tumor Microenvironment
    Joham Choque‐Velasquez, Szymon Baluszek, Roberto Colasanti, Sajjad Muhammad, Juha Antero Hernesniemi · 2020 · Advances in experimental medicine and biology
  19. Effects of primary granulocyte‑colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors
    Nikola Hapakova, Michal Chovanec, Katarína Rejleková, Katarína Kaľavská, Jana Obertová, Patrik Palacka, Valentina De Angelis, Daniela Světlovská, Zuzana Syčová-Milá, Jozef Mardiak et al. · 2022 · Oncology Letters
  20. Lymph node metastasis as the initial symptom of a germ cell tumor in an adult: A case report
    Fang Guo, Hongbing Wang, Heshun Xia, Hongwei Shi, Peng Xu, Guoliang Pi · 2022 · Medicine
  21. Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer
    Jamaal Christopher Jackson, Darren Sanchez, Andrew C. Johns, Matthew T. Campbell, Ahmet Murat Aydın, Neriman Gökden, Sanjay Maraboyina, Jason L. Muesse, John Francis Ward, Louis L. Pisters et al. · 2024 · Journal of Clinical Medicine
  22. An update on immunotherapy in uro-oncology
    Alessia Cimadamore, Alessandro Rizzo, Veronica Mollica, Francesco Massari, Antonio Lopez-beltran B, Marina Scarpelli, Liang Cheng C, Matteo Santoni, Rodolfo Montironi · 2021 · Expert Review of Precision Medicine and Drug Development
  23. Biomarkers of prostate bladder and testicular cancers: current use in anatomic pathology and future directions
    Mariana Andozia Morini, Daniel Abensur Athanazio, Luiza Fadul Gallas, José Maurício Mota, Stephania Martins Bezerra, João Lobo, María Belén Molina Froján, Andres Martin Acosta · 2024 · Surgical and Experimental Pathology
  24. Clinical outcome and prognostic factors for immunotherapy-based treatments in patients with platinum-refractory germ cell tumor
    Riqing Huang, Ditian Shu, Haifeng Li, Anqi Hu, Meiting Chen, Wei Yang, Y X Zhang, Qiufan Zheng, Xin An, Cong Xue et al. · 2024 · International Immunopharmacology
  25. Case report: Successful treatment of advanced urothelial carcinoma with trophoblastic differentiation using Tislelizumab and Disitamab vedotin
    Yaqian Han, Yujuan Zhou, Zheng Wu, Lin Liu, Chen Han · 2024 · Heliyon
  26. Immune Checkpoint Inhibitors in Patients with Testicular Cancer: A Systematic Review
    Carlos Eduardo Salazar-Mejía, Rosalaura Virginia Villarreal-González, Óscar Vidal-Gutiérrez, Carlos Cruz, Estefanía Guadarrama-Rendón, Sofia Alejandra Alvarado-Ruiz, Andrea Sarahi Guerra-Garza, Ramiro Quiroz-Huerta, Karina Alicia Salazar-Salazar, Neri Alejandro Álvarez‐Villalobos · 2024 · Journal of Adolescent and Young Adult Oncology
  27. Primary yolk sac tumor of the gluteus: a case report and literature review
    Ling-Ou Yang, Qianqian Jiang, Shitai Zhang, Yang Zhou, qing-fu zhang, Bo Li · 2016 · OncoTargets and Therapy
  28. Immunothérapie en uropathologie
    Virginie Verkarre, Hélène Roussel, Clémence Granier, Éric Tartour, Yves Allory · 2017 · Annales de Pathologie
  29. Primary retroperitoneal choriocarcinoma with lung and liver metastasis in a male patient: case report
    Guimei Wang, Ronghui Li · 2024 · ONCOLOGIE
  30. Correlation between PD-L1 Expression, Clinicopathological Factors, and Metastasis Risk in Colorectal Cancer Patients
    Alireza Zarbakhsh, Amirreza Khalaji, Amir Vahedi, Roya Dolatkhah, Nasrin Gholami · 2024 · European Journal of Cancer Care
  31. PD-L1 expression in testicular germ cell tumors undergoing spontaneous regression
    Ivan Novak, Miroslav Tomić, Denis Mulabdić, Ivan Pezelj, Slaven Čiček, Igor Tomašković, Nino Sinčić, Božo Krušlin, Monika Ulamec · 2024 · Biomolecules and Biomedicine
  32. Phosphoribosyl transferase domain containing 1: A prognostic biomarker in testicular germ cell tumors
    Peisheng Huang, Yi‐Hao Chen, Yongcheng Shi, Chuanfan Zhong, Huawei Lin, Xiaoxue Yu, Kai Chen, Zhuoya Huang, Le Zhang, Shumin Fang et al. · 2025 · Molecular Therapy Oncology
  33. GRK5 as a Novel Therapeutic Target for Immune Evasion in Testicular Cancer: Insights from Multi-Omics Analysis and Immunotherapeutic Validation
    Congcong Xu, Qifeng Zhong, Nengfeng Yu, Xuqiang Zhang, Kefan Yang, Hao Liu, Ming Cai, Yichun Zheng · 2025 · Biomedicines
  34. Cisplatin-refraktäre Keimzelltumoren
    Christoph Oing, Christoph Alexander Seidel, Winfried H. Alsdorf, Carsten Bokemeyer · 2016 · Der Onkologe
  35. The potential of programmed death ligand-1 expression in ovarian malignant germ cell tumors as a prognostic factor
    Fadhlina Muharmi Harahap, Hartono Tjahjadi, Kusmardi Kusmardi · 2020 · Revista română de medicină de laborator
  36. Evaluation PD-L1, CD8 and CD20 as early predictor and tracking markers for breast cancer (BC) in Egypt
    Manar Hamed, Mona S. O. Gouida, Sameh R. Abd EL-Aziz, Ahmed M.A. El-Sokkary · 2022 · Heliyon
  37. Metastatic Germ Cell Tumor Showing a Durable Response to the Anti-PD-1 Antibody Toripalimab
    Ruiqi Wang, Wanning Wang, Wenlong Zhang, Yuansong Bai · 2023 · Immunotherapy
  38. The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group ( TOG ) study
    Deniz Can Güven, Musa Barış Aykan, Harun Muğlu, Ertuğrul Bayram, Kaan Helvacı, Bengü Dursun, Melisa Celayir, Elvin Celebiyev, Erdinç Nayır, Mustafa Erman et al. · 2023 · Cancer Medicine
  39. PD-L1: a promising target for TGCTs
    Rebecca Kelsey · 2015 · Nature Reviews Urology
  40. Molecular Pathogenesis of Testicular Germ Cell Tumors
    Violeta Bakardjieva-Mihaylova, Karolina Škvárová Kramarzová, Martina Slámová, Tomáš Büchler, Ludmila Boublíková · 2017 · Klinicka onkologie
  41. Systemic Therapies for Metastatic Testicular Germ Cell Tumors: Past, Present and Future
    Sunil Parimi, Jennifer Marie Rauw, Jenny Jaeeun Ko · 2018 · Current Cancer Therapy Reviews
  42. La adquisición de la propiedad por subasta en los procesos de ejecución: Comentario a la Sentencia del Tribunal Supremo (Sala 1ª) de 24 de junio de 1997
    Miguel Navarro Castro · 1998 · Revista chilena de derecho privado
  43. The effect of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with testicular germ cell tumors
    Nikola Hapakova, Michal Chovanec, Katarína Rejleková, Katarína Kaľavská, Jana Obertová, Patrik Palacka, Valentina De Angelis, Daniela Světlovská, Zuzana Syčová-Milá, Jozef Mardiak et al. · 2020 · Research Square
  44. The effect of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with testicular germ cell tumors
    Nikola Hapakova, Michal Chovanec, Katarína Rejleková, Katarína Kaľavská, Jana Obertová, Patrik Palacka, Valentina De Angelis, Daniela Světlovská, Zuzana Syčová-Milá, Jozef Mardiak et al. · 2020 · Research Square
  45. Immuno-Oncologic Treatment of Genitourinary Malignancies
    Przemyslaw W. Twardowski · 2022 · Springer eBooks
  46. The Expression of Programmed Death Ligand-1 (Pd-L1) in Testicular Seminoma as Potential Prognostic Factor
    Freciyana Boedijono, Budiana Tanurahardja, Ria Kodariah · 2020 · Majalah Patologi Indonesia
  47. Barrabiletako zelula germinalen minbizia eta konbertasak
    Aitziber Velado-Eguskiza, Laura Gómez‐Santos, Edurne Alonso · 2021 · Osagaiz osasun-zientzien aldizkaria
  48. Unraveling drug resistance mechanisms in testicular cancer through immune cell phenotypes: a bidirectional Mendelian randomization analysis revealing novel therapeutic targets
    Xiao Lin, Tianen Wu · 2025 · Discover Oncology
  49. Immune cell profiling of peripheral blood in long-term testicular germ cell tumor survivors
    Kristina Kilikova, Andrea Mlcakova, Zuzana Šestáková, Katarína Kaľavská, Kristyna Adamikova, Jana Obertová, Patrik Palacka, Katarína Rejleková, Zuzana Syčová-Milá, Valentina De Angelis et al. · 2025 · Frontiers in Immunology
  50. Additional file 6 of Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
    Margaretha A. Skowron, Mara Kotthoff, Felix Bremmer, K. Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter‐Jessen, Stella Pauls, Anja Stefanski et al. · 2024 · Figshare
  51. Additional file 4 of Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
    Margaretha A. Skowron, Mara Kotthoff, Felix Bremmer, K. Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter‐Jessen, Stella Pauls, Anja Stefanski et al. · 2024 · Figshare
  52. Additional file 5 of Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
    Margaretha A. Skowron, Mara Kotthoff, Felix Bremmer, K. Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter‐Jessen, Stella Pauls, Anja Stefanski et al. · 2024 · Figshare
  53. Additional file 7 of Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
    Margaretha A. Skowron, Mara Kotthoff, Felix Bremmer, K. Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter‐Jessen, Stella Pauls, Anja Stefanski et al. · 2024 · Figshare
  54. Additional file 3 of Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
    Margaretha A. Skowron, Mara Kotthoff, Felix Bremmer, K. Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter‐Jessen, Stella Pauls, Anja Stefanski et al. · 2024 · Figshare
  55. Additional file 2 of Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
    Margaretha A. Skowron, Mara Kotthoff, Felix Bremmer, K. Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter‐Jessen, Stella Pauls, Anja Stefanski et al. · 2024 · Figshare
  56. Additional file 1 of Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
    Margaretha A. Skowron, Mara Kotthoff, Felix Bremmer, K. Ruhnke, Fatma Parmaksiz, Annika Richter, Stefan Küffer, Kirsten Reuter‐Jessen, Stella Pauls, Anja Stefanski et al. · 2024 · Figshare
  57. Loss of piR-hsa-7221 regulation drives the expression of the LINE1-derived oncogenic lncRNA CASC9 in testicular cancer
    Ahmad Zyoud, Ryan P Cardenas, Nabeelah Almalki, Tinyiko K. Modikoane, Mohammed Ageeli Hakami, Mansour Abdulaziz Alsaleem, Cristina Tufarelli, Nigel Patrick Mongan, Cinzia Allegrucci · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Current problems in epidemiology, diagnosis and treatment of testicular cancer
    Михаил Павлович Корчагин, Соколов Егор Андреевич, D. Yu. Pushkar · 2026 · Cancer Urology
  59. Treatment options in platinum-refractory male germ cell cancers: current standards and future directions
    Marco Oltrecolli, Domiziana Alaimo, Fabrizio Di Costanzo, Giovanni Rosti, Pasquale Rescigno, Massimo Dominici, Winfried H. Alsdorf, Carsten Bokemeyer, Christoph Oing, Christoph Alexander Seidel · 2026 · Therapeutic Advances in Medical Oncology
  60. Bioinformatics mining and clinical validation of CD274 as a prognostic indicator in hepatocellular carcinoma
    Hansen Shi, Peijun Zhang, Qiping Wei, He He, Haiqi Wu, Tianyin Xiao, Tiancai Liu, Tao Zeng · 2026 · BMC Cancer
  61. HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation
    Ki Hong Kim, Dae Young Lee, Hee Jo Yang, Si Hyun Kim, Doo Sang Kim, Chang Ho Lee, Soon Auck Hong, Byung Hoon Chi, J G Lee, Youn Soo Jeon · 2026 · Cancer Treatment and Research Communications
  62. Driving precision medicine in testicular germ cell tumors: from preclinical models to clinical applications
    Nuno Tiago Tavares, Michelle Y. Liu, Rui Henrique, Cármen Jerónimo, Robert S. Weiss, João Lobo · 2026 · Therapeutic Advances in Medical Oncology
  63. Testicular Cancer
    Thomas F. Eleveld, F. W. Janssen, M. Mego, Leendert H. J. Looijenga · 2026 · Endocrinology
  64. From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors—A Systematic Review
    Andrei Bogdan Cutitaru, Irina Draga Caruntu, Raluca Anca Balan, Carmen Solcan, Cornelia Amălinei · 2026 · Medical Sciences